This grant supports the Moroccan Agency for Medicines and Health Products (AMMPS) as it transitions into an autonomous national regulatory authority and advances toward higher WHO maturity levels, in line with national reforms and public health priorities.  SHI supports implementation, manages fiduciary processes, and ensures disciplined execution, while AMMPS leadership drives technical direction and ownership.

A landmark multi-country investment advancing digital and AI-ready regulatory systems across National Regulatory Authorities and the African Medicines Agency.  The work advances digital systems, AI and Software-as-a-Medical-Device regulatory readiness, and the development of a 5–10-year continental digital and AI roadmap.

SHI supports implementation and ensures disciplined execution across national and continental workstreams, while governance, adoption, and long-term ownership remain with African institutions.